Table 1. Baseline Characteristics of UK Biobank Participants Included in This Study and Numbers of Outcome Events.
Characteristic | Mean (SD) or N (%) |
---|---|
Sample size | 367 703 (100) |
Male | 168 799 (45.9) |
Age at baseline | 57.2 (8.1) |
Body mass index | 27.3 (4.8) |
Systolic blood pressure | 137.6 (18.6) |
Diastolic blood pressure | 82.0 (10.1) |
Smoking status (current/ex/never)* | 37 866 (10.3)/185 704 (50.5)/143 777 (39.1) |
Alcohol status (current/ex/never)* | 342 797 (93.2)/12 732 (3.5)/11 646 (3.2) |
History of type 2 diabetes mellitus | 15 834 (4.3) |
Coronary artery disease | 29 278 (8.0) |
Ischemic cerebrovascular event (all) | 8084 (2.2) |
Ischemic stroke | 4602 (1.3) |
Transient ischemic attack | 3962 (1.1) |
Hemorrhagic stroke (all) | 1981 (0.5) |
Intracerebral hemorrhage | 1064 (0.3) |
Subarachnoid hemorrhage | 1084 (0.3) |
Aortic aneurysm (all) | 1849 (0.5) |
Abdominal aortic aneurysm | 1094 (0.3) |
Thoracic aortic aneurysm | 347 (0.1) |
Venous thromboembolism (all) | 14 097 (3.8) |
Deep vein thrombosis | 9454 (2.6) |
Pulmonary embolism | 6148 (1.7) |
Hypertension | 125 846 (34.2) |
Peripheral vascular disease | 3415 (0.9) |
Aortic valve stenosis | 2244 (0.6) |
Atrial fibrillation | 16 945 (4.6) |
Heart failure | 6712 (1.8) |
Chronic kidney disease | 6321 (1.7) |
Excluding 356 participants with smoking status absent and 528 participants with alcohol consumption status absent.